Your browser doesn't support javascript.
loading
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.
Abida, Wassim; Cheng, Michael L; Armenia, Joshua; Middha, Sumit; Autio, Karen A; Vargas, Hebert Alberto; Rathkopf, Dana; Morris, Michael J; Danila, Daniel C; Slovin, Susan F; Carbone, Emily; Barnett, Ethan S; Hullings, Melanie; Hechtman, Jaclyn F; Zehir, Ahmet; Shia, Jinru; Jonsson, Philip; Stadler, Zsofia K; Srinivasan, Preethi; Laudone, Vincent P; Reuter, Victor; Wolchok, Jedd D; Socci, Nicholas D; Taylor, Barry S; Berger, Michael F; Kantoff, Philip W; Sawyers, Charles L; Schultz, Nikolaus; Solit, David B; Gopalan, Anuradha; Scher, Howard I.
Afiliação
  • Abida W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cheng ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Armenia J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Middha S; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Autio KA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rathkopf D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Morris MJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Danila DC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Slovin SF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Carbone E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Barnett ES; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hullings M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hechtman JF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zehir A; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jonsson P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Stadler ZK; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Srinivasan P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Laudone VP; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Reuter V; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wolchok JD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Socci ND; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Taylor BS; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Berger MF; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kantoff PW; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Sawyers CL; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schultz N; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Solit DB; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gopalan A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Scher HI; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
JAMA Oncol ; 5(4): 471-478, 2019 Apr 01.
Article em En | MEDLINE | ID: mdl-30589920

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Instabilidade de Microssatélites / Reparo de Erro de Pareamento de DNA / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Instabilidade de Microssatélites / Reparo de Erro de Pareamento de DNA / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article